Our research & development team is constantly on the look out for new and promising hardware devices, which may support our mission to create powerful and effective therapy packages for patients in need around the world.
Our goal is to stay “hardware-agnostic”, in other words we do not intend to build only on one specific set of devices. The hardware market is developing very quickly, players come and go. The latest example of a device leaving the market is Thalmic’s Myo, an EMG biofeedback armband we have built some of our prototypes on. The design of our software infrastructure allows us to build on multiple alternative armbands and sensors, the market is pushing out a number of devices in this product category. Similarly, new Virtual Reality (VR) and Augmented Reality (AR) headsets are introduced to the market on an almost monthly basis, it’s an exciting and very promising time to be in this space, as we have never seen so many valuable and well-suited device for our purposes before.
Thalmic’s Myo EMG-biofeedback armband is no longer available.
Rewellio’s R&D team testing EMG-biofeedback devices